| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +200 | 0.76% | $417.10 | +$83,420 |
| Sells | 4 | -25,988 | 99% | $484.69 | -$12,596,155 |
| Net | -3 | -25,788 | -98% | -$12,512,735 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin J. McNamara | president and CEO, Director | $166,568,221 | -$5,783,385 | -3.4% | 24 Nov 2025 |
| Thomas C. Hutton | vice president, Director | $30,673,798 | 21 Oct 2025 | ||
| Michael D. Witzeman | VP & Chief Financial Officer | $28,933,824 | 21 Oct 2025 | ||
| Spencer S. Lee | executive vice president | $20,275,726 | -$2,519,099 | -11% | 19 Nov 2025 |
| Brian C. Judkins | VP and Chief Legal Officer | $19,239,111 | 21 Oct 2025 | ||
| Nicholas M. Westfall | Executive Vice President | $18,668,693 | -$4,224,163 | -18% | 04 Aug 2025 |
| Joel F. Gemunder | Director | $17,022,152 | 16 May 2022 | ||
| Joel L. Wherley | CEO - Vitas Healthcare | $14,871,910 | 21 Oct 2025 | ||
| David P. Williams | executive vice president & CFO | $10,995,016 | 13 Nov 2023 | ||
| George J. Walsh III | Director | $3,913,994 | +$83,420 | +2.2% | 04 Aug 2025 |
| Thomas P. Rice | Director | $3,401,842 | 20 May 2024 | ||
| Donald E. Saunders | Director | $3,203,503 | 16 May 2022 | ||
| Christopher J. Heaney | Director | $2,575,212 | 19 May 2025 | ||
| Andrea R. Lindell | Director | $2,417,385 | 26 Dec 2025 | ||
| Ron DeLyons | Director | $1,748,548 | 19 May 2025 | ||
| Patrick P. Grace | Director | $1,574,135 | -$69,509 | -4.2% | 09 Sep 2025 |
| John Meredith Mount Jr. | Director | $907,021 | 19 May 2025 | ||
| Eileen P. McCarthy | Director | $821,268 | 19 May 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|